Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Roches oral GLP-1 receptor agonist CT-996obtained in the $2.7 billion acquisition of Carmot Therapeuticsreduced body weight by more than 6% at four weeks versus placebo in a Phase I trial
These trials generally report common side effects and any serious adverse events
Always remember to seek medical advice when you need it
Contact your doctor immediately if you experience severe abdominal pain, persistent vomiting, blood in stool, signs of dehydration, or a significant increase in diarrhea frequency that differs from your baseline ulcerative colitis pattern
US$ 28.29
US$ 29.45
US$ 27.80
US$ 29.07
US$ 29.93
US$ 24.14
